Revenue
2018
2019
2020
2021
2022
2023
2024
2025
HARVARD BIOSCIENCE INC (HBIO)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $86.5M | $94.1M | $112.3M | $113.3M | $118.9M | $102.1M | $116.2M | $120.8M | $77.4M | $104.5M | $108.7M | $108.7M | $105.2M | $111.2M | $108.9M | $108.2M | $85.8M |
| Gross profit | $49.9M | $54.8M | $66.1M | $60.8M | $67.7M | $58.0M | $64.3M | $63.2M | $39.2M | $48.4M | $48.7M | $49.3M | $47.7M | $52.3M | $50.2M | $51.8M | $41.7M |
| Research & development | $8.8M | $10.4M | $11.8M | $12.3M | $10.8M | $8.7M | $10.7M | $11.0M | $5.6M | $5.4M | $6.4M | $4.9M | $4.2M | $4.3M | $3.9M | $4.7M | $4.4M |
| Operating expenses | $98.5M | $61.0M | $64.2M | $67.8M | $65.6M | $57.8M | $63.9M | $62.2M | $39.8M | $51.4M | $50.4M | $42.7M | $46.2M | $44.5M | $41.8M | $41.6M | $33.6M |
| Operating income | −$48.6M | −$6.2M | $1.9M | −$6.9M | $2.1M | $221,000 | $377,000 | $984,000 | −$635,000 | −$3.0M | −$1.7M | $6.6M | $1.5M | $7.8M | $8.4M | $10.2M | $8.1M |
| EBITDAderived | −$42.8M | $771,000 | $8.9M | $642,000 | $9.7M | $7.9M | $8.1M | $8.8M | $2.2M | $1.3M | $2.9M | $10.4M | $5.4M | $12.0M | $12.7M | $14.1M | $11.1M |
| Net income | −$56.7M | −$12.4M | −$3.4M | −$9.5M | −$288,000 | −$7.8M | −$4.7M | −$2.9M | −$865,000 | −$4.3M | −$19.0M | $2.4M | −$1.8M | $2.4M | $3.8M | $19.0M | $7.2M |
| Basic EPSper diluted share | -$1.28 | -$0.28 | -$0.08 | -$0.23 | -$0.01 | -$0.20 | -$0.12 | -$0.08 | -$0.02 | -$0.13 | -$0.57 | $0.07 | -$0.06 | $0.09 | $0.14 | $0.66 | $0.24 |
| Diluted EPSper diluted share | -$1.28 | -$0.28 | -$0.08 | -$0.23 | -$0.01 | -$0.20 | -$0.12 | -$0.08 | -$0.02 | -$0.13 | -$0.57 | $0.07 | -$0.06 | $0.08 | $0.13 | $0.65 | $0.24 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 17, 2026Form 4 | DENELSKY STEPHEN JDirector | BuyCommon Stock | 10.0K | $4.87 | $48.7K | 21.0K |
| Mar 17, 2026Form 4 | Snider WilliamDirector | BuyCommon Stock | 8.5K | $4.85 | $41.1K | 32.0K |
| Mar 16, 2026Form 4 | Frost Mark TChief Financial Officer | BuyCommon Stock | 5.0K | $5.00 | $25.0K | 17.5K |
| Mar 16, 2026Form 4 | Snider WilliamDirector | BuyCommon Stock | 12.5K | $4.99 | $62.5K | 23.5K |
| Mar 16, 2026Form 4 | Duke John DChief Executive Officer | BuyCommon Stock | 5.0K | $5.01 | $25.1K | 105.0K |